Our uniqueness begins with a deep understanding of what really counts in the pharmaceutical and medical products industries.
Catenion is convinced that the core element of success in this industry is not to develop fancy “winning strategies.” Rather, we believe the key is to build organisations that can make good decisions in the face of unusually high risks and long timelines.
This is why we have long focused on understanding what drives the behaviour and creativity of scientists, technicians and managers, as well as developing tools and methods for decision analysis that address the specific requirements of this industry.
We do not claim to bring ready–made answers to our clients. But we have developed an in–depth understanding of the key drivers of the industry, and our partners and consultants are well–equipped to challenge scientists and executives so as to improve the quality of decision–making at the level of R&D projects, therapeutic areas and the company.
Importantly, in our assignments we develop a strong, independent point of view rooted in the objective reality and requirements of our clients as we see them. To us the key function of this point of view is to act as a catalyst to push people out of their comfort zones without losing the organisation. One might call it the “therapeutic approach” to strategy consulting.